MediGene Company
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Total Funding:
29379427
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
$10M to $50M
Founded Date:
1994-01-01
Industry:
CAR-T/TCR
Employee Number:
11-50
Last Funding Date:
2022-02-02
Funding Status:
IPO
Headquarters:
Martinsried, Bayern, Germany
Investors Number:
1